Grants in Norway

Closed

Funds two projects, worth up to EUR 4 million each, to develop European-supplied chip scale atomic clocks or space solar cells free of non-EU export restrictions.

Closed

Funds feasibility studies for satellite-enabled municipal services.

Closed

Funds student teams at Norwegian universities and colleges developing and commercialising a business idea through a grant.

Closed

Supports sustainable seafood by-product valorisation through research into antioxidant formulations for silage production and product stability.

Closed

Supports aquaculture design improvements by generating tank and model data that validate facility sizing and engineering calculations.

Closed

Supports evidence-based understanding of wild salmon survival by mapping ecological factors affecting coexistence with aquaculture.

Closed

Funds feasibility studies for satellite-enabled wildlife-protection services.

Discontinued

Invests minority equity in Norwegian climate-tech companies alongside private investors who retain control.

Discontinued

Backs Nordic and select international climate-focused venture and private equity funds as an anchor partner.

Discontinued

Funds Norwegian pre-seed ecosystems through commitments to managers and follow-on private co-investment.

Open

Funds a €7M platform giving adolescent and young adult cancer patients and survivors personalized digital tools for coping and psychological support.

Open

Funds a €15M project that turns microbiome signals into a test for spotting cancer risk years ahead of any symptoms.

Open

Funds five projects, €5-6M each, that develop and test care approaches built around what cancer patients over 65 actually need during and after treatment.

Open

Funds three €5M projects that build earlier, AI-assisted palliative care models for cancer patients and test them in real clinical and home-based settings.

Open

Funds a €5M programme that pairs EU and Associated Country research institutions with Ukrainian cancer centres for joint training and staff exchanges.

Open

Funds up to four €8-9M grants for teams building AI-driven digital models of a patient's cancer to predict how it develops and guide personalised treatment.

Open

Funds three pragmatic clinical trials, €7-8M each, testing existing cancer immunotherapies in real-world care for patients whose disease resists treatment.

Open

Funds eight €15–25M lump-sum projects that turn carbon capture, clean energy and circular production ideas into market-ready industrial demonstrations.

Open

Funds €15–25M lump-sum projects led by industry to mature energy, power, storage, fuels or CCU solutions from TRL 6 to market-ready deployment.

Open

Funds EU teams hardening AI systems against adversarial attacks and building privacy-preserving AI for sensitive government and enterprise use.

Open

Funds €2-3M projects building post-quantum cryptographic schemes for digital ID wallets, or formally verified high-assurance cryptographic software.

Open

Funds five lump-sum grants, each €3-4M, for tools that harden chip design or software supply chains against tampering, backdoors, and compromised dependencies.

Open

Funds a single €1.6M project to build a shared EU nuclear training curriculum and cross-border qualification recognition, from technicians to regulators.

Open

Funds rare-disease research calls, clinical trial networks and shared data for ERDERA's second phase — open only to the existing coordinator.